» Articles » PMID: 27738316

Mitotic Arrest-induced Phosphorylation of Mcl-1 Revisited Using Two-dimensional Gel Electrophoresis and Phosphoproteomics: Nine Phosphorylation Sites Identified

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Oct 15
PMID 27738316
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Microtubule targeting agents (MTAs) characteristically promote phosphorylation and degradation of Mcl-1, and this represents a critical pro-apoptotic signal in mitotic death. While several phosphorylation sites and kinases have been implicated in mitotic arrest-induced Mcl-1 phosphorylation, a comprehensive biochemical analysis has been lacking. Contrary to previous reports suggesting that T92 phosphorylation by Cdk1 regulates Mcl-1 degradation, a T92A Mcl-1 mutant expressed in HeLa cells was phosphorylated and degraded with the same kinetics as wild-type Mcl-1 following vinblastine treatment. Similarly, when Mcl-1 with alanine replacements of all five putative Cdk sites (S64, T92, S121, S159, T163) was expressed, it was also phosphorylated and degraded in response to vinblastine. To analyze Mcl-1 phosphorylation in more detail, two-dimensional gel electrophoresis (2D-PAGE) was performed. While untreated cells expressed mainly unphosphorylated Mcl-1 with two minor phosphorylated species, Mcl-1 from vinblastine treated cells migrated during 2D-PAGE as a train of acidic spots representing nine or more phosphorylated species. Immunopurification and mass spectrometry of phosphorylated Mcl-1 derived from mitotically arrested HeLa cells revealed nine distinct sites, including several previously unreported. Mcl-1 bearing substitutions of all nine sites had a longer half-life than wild-type Mcl-1 under basal conditions, but still underwent phosphorylation and degradation in response to vinblastine treatment, and, like wild-type Mcl-1, was unable to protect cells from MTA treatment. These results reveal an unexpected complexity in Mcl-1 phosphorylation in response to MTAs and indicate that previous work has severely underestimated the number of sites, and thus encourage major revisions to the current model.

Citing Articles

Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways.

Delgado M, Rainwater R, Heflin B, Urbaniak A, Butler K, Davidson M J Biol Chem. 2022; 298(6):101939.

PMID: 35436470 PMC: 9123221. DOI: 10.1016/j.jbc.2022.101939.


Saga of Mcl-1: regulation from transcription to degradation.

Senichkin V, Streletskaia A, Gorbunova A, Zhivotovsky B, Kopeina G Cell Death Differ. 2020; 27(2):405-419.

PMID: 31907390 PMC: 7206148. DOI: 10.1038/s41418-019-0486-3.


Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents.

Whitaker R, Placzek W Cells. 2019; 8(4).

PMID: 31013740 PMC: 6523793. DOI: 10.3390/cells8040346.


Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies.

Lin M, Ye M, Zhou J, Wang Z, Zhu X Comput Struct Biotechnol J. 2019; 17:241-250.

PMID: 30847042 PMC: 6389684. DOI: 10.1016/j.csbj.2019.02.001.


Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia.

Nair R, Piktel D, Geldenhuys W, Gibson L Leuk Res. 2018; 72:59-66.

PMID: 30103201 PMC: 6414069. DOI: 10.1016/j.leukres.2018.08.002.


References
1.
Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo P, Kitada S . Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 2006; 10(5):375-88. DOI: 10.1016/j.ccr.2006.10.006. View

2.
Eichhorn J, Alford S, Sakurikar N, Chambers T . Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival. Exp Cell Res. 2014; 322(2):415-24. PMC: 3977614. DOI: 10.1016/j.yexcr.2014.02.010. View

3.
Perciavalle R, Opferman J . Delving deeper: MCL-1's contributions to normal and cancer biology. Trends Cell Biol. 2012; 23(1):22-9. PMC: 3532576. DOI: 10.1016/j.tcb.2012.08.011. View

4.
Clarke P, Allan L . Destruction's our delight: controlling apoptosis during mitotic arrest. Cell Cycle. 2010; 9(20):4035-6. DOI: 10.4161/cc.9.20.13522. View

5.
Kobayashi S, Lee S, Meng X, Mott J, Bronk S, Werneburg N . Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1. J Biol Chem. 2007; 282(25):18407-18417. DOI: 10.1074/jbc.M610010200. View